Literature DB >> 16191503

Biliary brush cytology and the detection of cholangiocarcinoma in primary sclerosing cholangitis: evaluation of specific cytomorphologic features and CA19-9 levels.

Paul S Furmanczyk1, Verena S Grieco, S Nicholas Agoff.   

Abstract

Interpreting biliary brush cytology (BBC) findings in primary sclerosing cholangitis (PSC) is problematic. In our study, BBC findings and CA19-9 serum levels were evaluated for their effectiveness in diagnosing cholangiocarcinoma in patients with PSC. We reviewed 107 biliary brushings from 51 patients with PSC and concurrent CA19-9 levels between January 1995 and March 2004 at the University of Washington Medical Center, Seattle. A portion of the brushings were evaluated and scored according to specific cytologic criteria; statistical analysis showed which criteria were most predictive in diagnosing malignancy: nuclear/cytoplasmic ratio, prominent nucleoli, nuclear membrane irregularities, and discohesion were significant predictive features. Sensitivity and specificity of BBC were 62.5% and 100%, respectively. Sensitivity and specificity of CA19-9 at a cutoff of 186 IU/mL were 100% and 94%, respectively. BBC is a specific and relatively sensitive method of detecting cholangiocarcinoma, even in patients with PSC, especially when certain cytomorphologic features are identified. Combining biliary cytology and CA19-9 levels might have an important diagnostic role in PSC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16191503     DOI: 10.1309/J030-JYPW-KQTH-CLNJ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  21 in total

1.  Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma.

Authors:  Kawin Leelawat; Siriluck Narong; Jerasak Wannaprasert; Thawee Ratanashu-ek
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

Review 2.  Current state of nonsurgical therapies for cholangiocarcinoma.

Authors:  Volker Brass; Jan B Kuhlmann; Hubert E Blum
Journal:  Hepat Oncol       Date:  2013-12-20

Review 3.  Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy.

Authors:  Domenico Viterbo; Valerie Gausman; Tamas Gonda
Journal:  World J Gastrointest Endosc       Date:  2016-02-10

Review 4.  Cholangiocarcinoma: has there been any progress?

Authors:  Judith Meza-Junco; Aldo J Montano-Loza; Mang Ma; Winnie Wong; Michael B Sawyer; Vincent G Bain
Journal:  Can J Gastroenterol       Date:  2010-01       Impact factor: 3.522

Review 5.  Emerging Technologies for the Diagnosis of Perihilar Cholangiocarcinoma.

Authors:  Sumera Rizvi; John Eaton; Ju Dong Yang; Vinay Chandrasekhara; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2018-06-05       Impact factor: 6.115

Review 6.  Approach to a patient with elevated serum alkaline phosphatase.

Authors:  Asma Siddique; Kris V Kowdley
Journal:  Clin Liver Dis       Date:  2012-04-06       Impact factor: 6.126

Review 7.  Primary sclerosing cholangitis: detection of cancer in strictures.

Authors:  Richard D Schulick
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

Review 8.  Primary sclerosing cholangitis.

Authors:  Marina G Silveira; Keith D Lindor
Journal:  Can J Gastroenterol       Date:  2008-08       Impact factor: 3.522

Review 9.  Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.

Authors:  Sumera Rizvi; John E Eaton; Gregory J Gores
Journal:  Clin Gastroenterol Hepatol       Date:  2015-06-05       Impact factor: 11.382

10.  Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma?

Authors:  E Buc; M Lesurtel; J Belghiti
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.